U.S. markets open in 8 hours 58 minutes
  • S&P Futures

    3,837.00
    +27.75 (+0.73%)
     
  • Dow Futures

    31,099.00
    +187.00 (+0.60%)
     
  • Nasdaq Futures

    13,057.75
    +146.75 (+1.14%)
     
  • Russell 2000 Futures

    2,231.30
    +32.10 (+1.46%)
     
  • Crude Oil

    62.53
    +1.03 (+1.67%)
     
  • Gold

    1,748.80
    +20.00 (+1.16%)
     
  • Silver

    26.98
    +0.53 (+2.02%)
     
  • EUR/USD

    1.2085
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.4600
    -1.5180 (-100.00%)
     
  • Vix

    27.95
    -28.89 (-100.00%)
     
  • GBP/USD

    1.3982
    +0.0060 (+0.43%)
     
  • USD/JPY

    106.5210
    +0.0190 (+0.02%)
     
  • BTC-USD

    46,280.46
    +1,426.93 (+3.18%)
     
  • CMC Crypto 200

    923.76
    -9.37 (-1.00%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    29,594.59
    +628.58 (+2.17%)
     

WHO issues new clinical advice on treating COVID-19 patients

·1 min read

GENEVA, Jan 26 (Reuters) - The World Health Organization (WHO) issued fresh clinical advice on Tuesday for treating COVID-19 patients, including those displaying persistent symptoms after recovery, and also said it advised using low-dose coagulants to prevent blood clots.

WHO spokeswoman Margaret Harris told a U.N. briefing in Geneva that a WHO-led team of independent experts, currently in the central Chinese city of Wuhan where the first human cases were detected in December 2019, is due to leave quarantine in the next two days to pursue its work on the virus origins.

Harris declined to commment on reports of delays in roll-out of vaccines in the European Union. She said she had no specific data and the WHO's priority was for health workers in all countries to be vaccinated in the first 100 days of the year.

(Reporting by Stephanie Nebehay and Emma Farge)